Quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human plasma by liquid chromatography-tandem mass spectrometry following automated solid-phase extraction.

A. Schuster,S. Burzawa,M. Jemal,E. Loizillon,Philippe Couerbe,D. Whigan
DOI: https://doi.org/10.1016/S1570-0232(03)00063-1
2003-05-25
Abstract:
What problem does this paper attempt to address?